The cytoptrotection of small intestinal submucosa‐derived gel in HL‐1 cells during hypoxia/reoxygenation‐induced injury

Su‐Ya Wang,Jiang‐Wei Sang,Wei Ding,Ting‐Wu Qin,Lin Bai,Jie Zhang,Jing‐Cong Luo
DOI: https://doi.org/10.1002/term.2878
2019-07-18
Journal of Tissue Engineering and Regenerative Medicine
Abstract:Small intestinal submucosa (SIS)‐derived gel injected into infarcted myocardium has been shown to promote repair and regeneration after myocardial infarction (MI); however, the specific impact of SIS gel on cardiomyocytes remained unknown. The aim of this study was to characterize SIS gel function in hypoxia‐reoxygenation (H/R)‐induced cardiomyocyte damage and its potential mechanism. HL‐1 cardiomyocytes seeded on SIS matrix‐coated plates, SIS gel, and uncoated plates were subjected to H/R, cell viability, apoptosis, expression of caspase‐3, Bcl‐2, and Bax were investigated. SIS gel and SIS matrix as coating substrates markedly improved cell viability, preventing cell apoptosis compared to uncoated plates, with SIS gel yielding the best cytoprotective effects. SIS gel down‐regulated pro‐inflammatory cytokines (TNF‐α, CCL2, and IL‐6) expression through suppression the JNK‐MAPK/NF‐κB pathways. Furthermore, SIS gel protected cardiomyocytes from apoptosis by activating AKT and ERK pathways, and markedly up‐regulated anti‐apoptotic Bcl‐2 expression but inhibited that of pro‐apoptotic Bax and c‐caspase 3. Together, these findings show that SIS gel could decrease H/R‐induced cell apoptosis through a mechanism potentially related to its ability to regulate expression of inflammatory cytokines and anti‐apoptosis signaling pathways to prevent cell apoptosis. Our findings thereby shed light on the mechanism related to SIS gel therapeutic efficacy for myocardial infarction.
biotechnology & applied microbiology,engineering, biomedical,cell & tissue engineering,cell biology
What problem does this paper attempt to address?